Article Details

Dr. Steven Schmid Joins CTT to Oversee Advanced Lab Capabilities

Retrieved on: 2021-03-24 14:03:45

Tags for this article:

Click the tags to see associated articles and topics

Dr. Steven Schmid Joins CTT to Oversee Advanced Lab Capabilities. View article details on hiswai:

Excerpt

... experience in clinical trials, Phases I-IV in oncology, urologic oncology, small molecules, interferons, monoclonal antibodies, and liposomal agents.

Article found on: www.prweb.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up